These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 19593124)
21. Comparison of coronary atherosclerotic volume in patients with glomerular filtration rates < or = 60 versus > 60 ml/min/1.73 m(2): a meta-analysis of intravascular ultrasound studies. Nicholls SJ; Tuzcu EM; Hsu A; Wolski K; Sipahi I; Schoenhagen P; Crowe T; Kapadia SR; Hazen SL; Nissen SE Am J Cardiol; 2007 Mar; 99(6):813-6. PubMed ID: 17350372 [TBL] [Abstract][Full Text] [Related]
22. [Relationship between coronary risk calculation and distribution of the coronary artery lesions and risk factors]. Sağ C; Ozkan M; Uzun M; Yokuşoğlu M; Baysan O; Erinç K; Işik E Anadolu Kardiyol Derg; 2006 Dec; 6(4):353-7. PubMed ID: 17162284 [TBL] [Abstract][Full Text] [Related]
23. Towards a new era: is coronary artery disease reversible? Thompson GR Cardiology; 1990; 77 Suppl 4():66-9. PubMed ID: 2073674 [TBL] [Abstract][Full Text] [Related]
25. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients. Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535 [TBL] [Abstract][Full Text] [Related]
26. Findings of clinical trials that evaluate the impact of medical therapies on progression of atherosclerosis. Lavoie A; Uno K; Bayturan O; Nicholls SJ Curr Med Res Opin; 2010 Mar; 26(3):745-51. PubMed ID: 20092391 [TBL] [Abstract][Full Text] [Related]
27. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514 [TBL] [Abstract][Full Text] [Related]
28. [Assessment of progression and regression of coronary atherosclerosis by intravascular ultrasound. A new paradigm shift?]. Nicholls SJ; Sipahi I; Tuzcu EM Rev Esp Cardiol; 2006 Jan; 59(1):57-66. PubMed ID: 16434005 [TBL] [Abstract][Full Text] [Related]
29. Lessons from coronary intravascular ultrasound on the importance of raising high-density lipoprotein cholesterol. Nicholls SJ; Uno K; Tuzcu EM; Nissen SE Curr Atheroscler Rep; 2010 Sep; 12(5):301-7. PubMed ID: 20628836 [TBL] [Abstract][Full Text] [Related]
30. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
31. Effect of lipid modification on progression of coronary calcification. McCullough PA J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S115-9. PubMed ID: 16251246 [TBL] [Abstract][Full Text] [Related]
32. Analysis of missing mechanism in IVUS imaging clinical trials with missing covariates. Hu M; Zhou T J Biopharm Stat; 2011 Mar; 21(2):282-93. PubMed ID: 21391002 [TBL] [Abstract][Full Text] [Related]
33. Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels. Kataoka Y; Hammadah M; Puri R; Duggal B; Uno K; Kapadia SR; Murat Tuzcu E; Nissen SE; Nicholls SJ Atherosclerosis; 2015 Oct; 242(2):490-5. PubMed ID: 26298740 [TBL] [Abstract][Full Text] [Related]
34. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. Nicholls SJ; Tuzcu EM; Kalidindi S; Wolski K; Moon KW; Sipahi I; Schoenhagen P; Nissen SE J Am Coll Cardiol; 2008 Jul; 52(4):255-62. PubMed ID: 18634979 [TBL] [Abstract][Full Text] [Related]
35. [Effect of the LDL-/HDL-cholesterol quotient on progression and regression of arteriosclerotic lesions. An analysis of controlled angiographic intervention studies]. Gohlke H Wien Klin Wochenschr; 1992; 104(11):309-13. PubMed ID: 1621390 [TBL] [Abstract][Full Text] [Related]
36. Progression and regression of atherosclerosis, what roles for LDL-cholesterol and HDL-cholesterol: a perspective. Barth JD; Arntzenius AC Eur Heart J; 1991 Aug; 12(8):952-7. PubMed ID: 1915434 [TBL] [Abstract][Full Text] [Related]
37. Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study. Nicholls SJ; Sipahi I; Schoenhagen P; Wisniewski L; Churchill T; Crowe T; Goormastic M; Wolski K; Tuzcu EM; Nissen SE; Am Heart J; 2006 Jul; 152(1):67-74. PubMed ID: 16824833 [TBL] [Abstract][Full Text] [Related]
38. Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study. Hodis HN J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S25-31. PubMed ID: 8907211 [TBL] [Abstract][Full Text] [Related]
39. Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk. Palazón CP; Alfón J; Gaffney P; Berrozpe M; Royo T; Badimon L Atherosclerosis; 1998 Feb; 136(2):333-45. PubMed ID: 9543105 [TBL] [Abstract][Full Text] [Related]
40. Comparison of coronary plaque composition among patients with acute coronary syndrome and stable coronary artery disease. Li XM; Huang CX; Wang TS; Zhuang SW; Zhou H; Tian B Chin Med J (Engl); 2008 Mar; 121(6):534-9. PubMed ID: 18364141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]